Paolo Cavazza
Nessuna posizione attualmente
Patrimonio netto: 11 M $ in data 30/04/2024
Profilo
Paolo Cavazza worked as a Principal at SciClone Pharmaceuticals LLC.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2023 | 76 580 898 ( 13.01% ) | 11 M $ | 30/04/2024 |
Precedenti posizioni note di Paolo Cavazza
| Società | Posizione | Fine |
|---|---|---|
| SCICLONE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
- Borsa valori
- Insiders
- Paolo Cavazza
